TCT 459: Cardiac power output or stroke volume index to predict outcome in transcatheter aortic valve implantation

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker’s Bureau - Abbott Vascular; Edwards Lifesciences; Abiomed; Boston Scientific Corporation; AstraZenca; Bristol-Myers Squibb; Bayer AG; Sanofi-Aventis; Medtronic; Novartis